• 1. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

Professional Introduction to 3-(Bromomethyl)-2-fluoropyridine hydrobromide (CAS No. 31140-59-7)

3-(Bromomethyl)-2-fluoropyridine hydrobromide is a significant compound in the realm of chemical and pharmaceutical research, characterized by its unique structural and functional properties. This compound, identified by the CAS number 31140-59-7, has garnered considerable attention due to its versatile applications in the synthesis of various bioactive molecules. The presence of both a bromomethyl group and a fluoropyridine core makes it an invaluable intermediate in medicinal chemistry, particularly in the development of novel therapeutic agents.

The bromomethyl group, a highly reactive electrophile, facilitates nucleophilic substitution reactions, enabling the facile introduction of diverse functional moieties. This reactivity is particularly useful in constructing complex molecular architectures, which are often required for achieving high binding affinity and selectivity in drug design. On the other hand, the fluoropyridine moiety contributes to the compound's overall pharmacological profile by influencing solubility, metabolic stability, and interaction with biological targets. The hydrobromide salt form enhances the compound's solubility in polar solvents, making it more amenable to various synthetic protocols.

In recent years, 3-(Bromomethyl)-2-fluoropyridine hydrobromide has been extensively studied for its potential in the synthesis of small-molecule inhibitors targeting various disease pathways. For instance, researchers have leveraged its reactivity to develop inhibitors of kinases and other enzymes implicated in cancer and inflammatory diseases. The fluorine atom's electronic properties also make it an attractive feature for modulating drug-receptor interactions, as fluorinated pyridines are known to improve pharmacokinetic profiles.

One notable application of this compound is in the synthesis of antiviral agents. The bromomethyl group allows for the introduction of sugar moieties or other protecting groups that are critical for mimicking natural substrates or inhibiting viral enzymes. Recent studies have demonstrated its utility in creating protease inhibitors that target viral replication cycles, highlighting its importance in antiviral drug development. Furthermore, the hydrobromide salt form ensures stability under various storage conditions, making it a reliable reagent for both laboratory-scale synthesis and industrial production.

The compound's significance extends beyond academic research; it has also found practical applications in industrial settings where scalable synthetic routes are essential. The ability to perform multi-step derivatization on 3-(Bromomethyl)-2-fluoropyridine hydrobromide allows chemists to tailor molecular structures with precision, leading to optimized pharmacological properties. This flexibility is particularly valuable in drug discovery programs where lead optimization is a critical step.

Advances in computational chemistry have further enhanced the utility of this compound by enabling virtual screening and molecular modeling studies. These approaches allow researchers to predict how modifications to the 3-(Bromomethyl)-2-fluoropyridine scaffold will affect biological activity. By integrating experimental data with computational insights, scientists can accelerate the discovery process and identify promising candidates for further development.

The role of fluorine-containing heterocycles in medicinal chemistry cannot be overstated. The unique electronic properties of fluorine atoms can significantly influence drug efficacy and safety profiles. In 3-(Bromomethyl)-2-fluoropyridine hydrobromide, the fluoropyridine ring contributes to favorable pharmacokinetic characteristics such as improved metabolic stability and reduced susceptibility to degradation by enzymatic pathways. These attributes are crucial for developing drugs with extended half-lives and enhanced therapeutic windows.

In conclusion, 3-(Bromomethyl)-2-fluoropyridine hydrobromide (CAS No. 31140-59-7) is a multifaceted compound with broad applications in pharmaceutical research and development. Its unique structural features enable diverse synthetic strategies, making it an indispensable tool for chemists working on next-generation therapeutics. As our understanding of disease mechanisms continues to evolve, compounds like this will play an increasingly pivotal role in addressing unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)